Syndax Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for cancer patients. The company focuses on entinostat, an oral HDAC inhibitor, and other epigenetic modulators in combination with immunotherapies and targeted agents. Syndax is advancing multiple clinical programs targeting both hematologic malignancies and solid tumors.